Name: Takeda Pharmaceutical Company Limited (TAK) Earnings Call
Start: 2026-10-29

Recent quarters

Latest 4 quarters

Beat in 2 of 4 · beat then fell 1 · average move ⁦±2.7%⁩

Quarter	EPSReported / estimate	RevenueReported / estimate	Reaction
Q1 FY2026 2026-07-30	0.23 / 0.17 +33.2%	7.66B / 7.13B	-2.82% ⁦-4.49⁩ pts vs SPY
Q4 FY2025 2026-05-13	0.28 / 0.21 +33.3%	6.92B / 7.14B	+1.34% ⁦+0.78⁩ pts vs SPY
Q3 FY2025 2026-01-29	0.48 / 0.55 -12.7%	7.73B / 7.54B	+2.88% ⁦+3.07⁩ pts vs SPY
Q2 FY2025 2025-10-30	0.44 / 0.44 0.0%	7.22B / 7.79B	-3.92% ⁦-2.82⁩ pts vs SPY

Reported / estimate

Q1 FY2026 · 2026-07-30-2.82%
EPS0.23 / 0.17+33.2%
Revenue7.66B / 7.13B
Q4 FY2025 · 2026-05-13+1.34%
EPS0.28 / 0.21+33.3%
Revenue6.92B / 7.14B
Q3 FY2025 · 2026-01-29+2.88%
EPS0.48 / 0.55-12.7%
Revenue7.73B / 7.54B
Q2 FY2025 · 2025-10-30-3.92%
EPS0.44 / 0.440.0%
Revenue7.22B / 7.79B

This company reports in JPY, and its reported revenue and the estimate may be in different currencies, so no revenue surprise or dollar sign is shown.

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.

Next report

2026-10-29

In 2 daysQ2 FY2026Time not announced· Expected date

EPS consensus: 0.14
Revenue consensus: 7.34B
Beat streak: 2

Latest result

89 days ago

⁦+33.2%⁩EPS Beat

2026-07-30Q1 FY2026BMO

EPS: Reported / estimate0.23 / 0.17
Revenue: 7.66B / 7.13B

Stock reaction

⁦-2.82%⁩

⁦-4.49⁩ pts vs SPY

Session ⁦2026-07-30⁩

Recent quarters

Revenue and stock reaction

Next report

Latest result

Stock reaction